Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube
    Latest

    Latest News

    TCT 2016: St Jude Medical to highlight latest cardiovascular portfolio

    Adherence to medication more powerful predictor of adverse outcomes than type of revascularisation

    FDA approve clinical trial of a miniature heart assist device for infants and children

    Health Canada grants licence to Medtronic for its CoreValve Evolut R system

    Vascular Solutions receive FDA clearance for its Fluent inflation device

    TCT 2016: First live case featuring Desolve NXT scaffold to be presented

    TCT 2016: Breakfast symposium to explore robotic therapy in interventional cardiology

    UK hospital to start largest study of its kind to evaluate minimally invasive sternotomy for mitral regurgitation patients

    US FDA issues Class I recall for 8040 Leonhard Lang multifunction defibrillation electrodes

    Positive top-line results for The Medicines Company’s PCSK9si

    St. Jude Medical and Abbott to sell portion of vascular closure and electrophysiology businesses to Terumo

    TCT 2016: Tryton Medical to hold clinical symposium on treatment of complex bifurcation lesions

    St Jude Medical to form cyber security medical advisory board

    Experience matters when stenting the left main

    Suzette Jaskie appointed as vice president Global Medical Affairs at Corindus Vascular Robotics

    Twitter “may be useful” for researching how general public discuss cardiovascular disease

    Mild-to-moderate chronic kidney disease no longer associated with worse outcomes after PCI

    Prophylactic ipsilateral ulnar compression significantly reduces risk of radial artery occlusion

    BioStable Science & Engineering completes direct de novo application to FDA for an aortic annuloplasty device

    FDA approves St Jude Medical’s PressureWire X guidewire

    Ian Meredith to become global chief medical officer of Boston Scientific

    New vice president of US market development for CVRx

    Data for The Medicines Company’s PCSK9si will be presented at AHA

    FDA deems two HeartWare HVAD recalls as “Class I”

    EACTS 2016: DuraGraft vascular graft treatment improves long-term outcomes after CABG

    Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent

    New brain lesions are found in 94% of patients following TAVI

    EACTS 2016: Positive one-year outcomes for Medtronic’s surgical aortic valve Avalus

    EACTS2016: World’s first heart valve that “enables cardiovascular restoration” successfully implanted in three children

    New “resilient” surgical aortic valve now available in Europe

    Heart team at Zurich University Hospital use Cardioband for tricuspid repair for the first time

    Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps

    Philips collaborates with World Heart Federation, launches health behaviours website

    Opsens receives 510(k) clearance for the OptoMonitor II providing extended indication

    Young women with premature acute coronary syndrome now do as well as men

    Visceral abdominal fat associated with newly-identified heart disease risk factors

    Xeltis established international clinical advisory board

    PCRLV 2016: MitraClip may be “safe and feasible” for treating tricuspid regurgitation

    PCRLV 2016: New approaches to TAVI are still being explored

    Smartphones can help to streamline hospital transfer for myocardial infarction patients

    TriGuard cerebral protection associated with significant improvements in brain protection in TAVI patients

    Positive top-line results from phase 3 GLAGOV imaging study of evolocumab

    Claret Medical submits application for FDA approval of its cerebral protection device

    Sapien 3

    Sapien 3 now approved for intermediate-risk patients in Europe as well as in the USA

    Transcatheter tricuspid valve repair performed at San Raffaele Hospital

    PCRLV 2016: Next-generation of Lotus TAVI receives CE mark

    Valtech to present first-in-human percutaneous tricuspid repair data at PCR London Valves

    First-in-human implants of Caisson Interventional’s percutaneous mitral valve device performed

    ESC 2016: Bare metal stents inferior to drug-eluting stents for saphenous vein graft PCI at three years

    Terumo’s FineDuo microcatheter receives CE mark

    CIRSE 2016: BTG launches βETA radiation safety programme

    TCT 2016: Pivotal trial on cerebral protection device to be presented as a late-breaker

    TCT 2016: Late-breakers and first report investigations announced

    Redo TAVI procedures are safe and feasible

    ESC 2016: Less unnecessary angiography with functional imaging

    Researchers find new carotid body-removal treatment for hypertension

    ESC launches European standards to prevent repeat heart attacks

    ESC 2016: Adding N-acetylcysteine to glyceryl trinitrate reduces infarct size by a third

    ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may be on the cards

    Berlin Heals announces closure of second round funding for cardiac microcurrent system

    No significant differences between Watchman and Amplatzer in first comparison

    ESC 2016: First head-to-head comparisons of prasugrel and ticagrelor shows no significant differences

    Vivasure Medical secures €16.2 million series C financing

    Risk factors for congenital heart defects may lie both inside and outside the heart

    Medtronic ranks on Dow Jones Sustainability North America Index for ninth consecutive year

    St Jude Medical launches trial of Amplatzer Amulet left atrial appendage occluder

    Pat Mackin appointed as a company director of Opsens

    ESC 2016: “Costly and complex” platelet monitoring strategy does not appear to benefit even high-risk patients

    ESC 2016: Off-hours STEMI patients do not have worse outcomes

    Women 50% more likely than men to be given incorrect diagnosis following heart attack

    Synthetic heart valves could help doctors improve surgical skills

    ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents

    ESC 2016: Low socioeconomic status associated with higher risk of second heart attack or stroke

    ESC launches paper on tackling cardiac toxicity of anticancer therapies

    Philips launches Intellispace Cardiovascular image and information management system

    Mediterranean diet linked to lower mortality in patients with a history of cardiovascular disease

    ESC and EACTS launch first collaborative atrial fibrillation guidelines

    Rose Medical Center among first hospitals in Colorado to offer Watchman

    Bolus version of Aggrastat is now approved in the USA

    More than half of women have sexual dysfunction in the year after a myocardial infarction

    Nicolas Meneveau

    ESC 2016: Optical coherence tomography significantly improves functional outcomes after PCI

    Fewer cardiovascular drugs being studied in clinical trials

    ESC 2016: Short-term DAPT is feasible with Nobori biodegradable polymer stent

    LifeVest

    Germany registry shows Zoll LifeVest wearable defibrillator to be safe and effective

    Automated external defibrillator accessibility: Barrier during cardiac arrest

    Philips to showcase “full suite” of cardiology solutions for diagnosis and treatment at ESC

    Purchase of HeartWare by Medtronic completed

    Zip surgical skin closure device associated with less pain for paediatric patients undergoing congenital heart surgery

    Gender should not be a primary concern when deciding DAPT duration

    No advantage with beta-blockers post PCI for stable angina patients without prior myocardial infarction

    Long-term study indicates no calcification with CardioCel after eight years

    CMS recognises LAAO Registry as approved registry to meet national coverage determination requirements

    FDA approval for Edwards Intuity Elite rapid deployment valve

    Two major studies of Combo dual therapy stent complete enrolment

    Edwards Sapien 3 granted expanded indication from US FDA

    Renal denervation devices are alternatives to drug therapy, Technavio reports

    Corindus Vascular Robotics and Acist collaborate to improve PCI workflow for physicians and patients

    Drug-coated scoring balloon receives CE mark

    Frequency of coronary perforation “might actually increase” given predictors include old age

    Cardiovascular researchers form consortium to address calls for data sharing

    CE mark granted to InSeal Medical for InClosure vascular closure device

    US FDA commissioner discusses future of cardiovascular medicine

    Mount Kilimanjaro climbing expedition to study effects of oxygen deprivation

    Boston Scientific issues urgent recall of Lotus systems manufactured prior to March 2016.

    Corindus appoints J Aaron Grantham as chief medical officer

    Essential Medical to start US trial of X-Seal 6F vascular closure device

    Medtronic CoreValve Evolut becomes first TAVI to receive CE mark for intermediate risk aortic stenosis patients

    Mediterranean diet without low-fat element reduces cardiovascular events

    Oral abstract on DuraGraft to be presented at EACTS

    US FDA releases draft guidance on real-world evidence and medical device regulation decisions

    ClearFlow launches smaller PleuraFlow active clearance technology for paediatric use

    Providence Health Care adopts HeartFlow FFRct Analysis to assess coronary artery disease

    New website for Xenios

    First patient enrolled in left main study of Xposition S

    Robotic-assisted PCI is safe and feasible for complex procedures

    AHA warn that some over-the-counter drugs may cause or worsen heart failure

    Health Canada approves Abbott Absorb stent

    Heart failure after first myocardial infarction linked to cancer

    Sunshine Heart to focus on neuromodulation for heart failure

    First single monthly injection of a PCSK9 Inhibitor approved in the USA

    Cardiovascular Systems submits Diamondback 360 Coronary Orbital Atherectomy System Micro Crown for approval in Japan

    CE mark for QT Vascular’s Chocolate Heart drug-coated balloon

    CorPath to be featured at San Diego Cardiovascular Interventions Course

    Study confirms safety of using Tryton stent to treat coronary bifurcation lesions involving large side branches

    Versa Capital Management to acquire SynCardia Systems

    Absorb now available in the USA following FDA approval

    High prevalence of delirium found in cardiac arrest patients with therapeutic hypothermia

    Industry-sponsored meals linked to increased rate of prescribing brand-name drugs

    FDA clears QT Vascular Chocolate XD balloon

    Twisting of the heart may predict mitral valve surgery outcomes

    Bioventrix receives CE marking for Revivent TC system

    RenalGuard features in high-risk live case at CTO Fundamentals Course

    Prior radiation therapy is associated with increased risk of mortality in PCI patients

    Next-generation of HeartFlow launched

    First patients treated with CorMatrix Cardiovascular Tyke

    First patient enrolled in AtriCure FROST cryoanalgesia study

    Small study finds positive results for Neovasc’s Reducer system treatment for refractory angina

    Immune system linked to lower heart attack risk, suggests study

    St Jude Medical HeartMate 3 wins CARDIOSTIM-EHRA EUROPACE 2016 Innovation Award

    Biotronik’s scaffold is now approved for use in Europe

    First patients treated with CorMatrix Cardiovascular Tyke

    First patient enrolled in AtriCure FROST cryoanalgesia study

    A quarter of an hour of exercise per day may reduce risk of death in older adults

    Biotronik’s scaffold is now approved for use in Europe

    Risk of device thrombosis may be significantly higher with Absorb than with Xience, Promus or Orsiro

    Minor short-term mortality benefit with vascular closure devices

    CE mark for longest version of Xposition S sirolimus-eluting stent

    Karl-Heinz Kuck steps down from the ESC and EHRA after fraud conviction

    Marriage is good for the heart

    Heart bleeds associated with severity of heart failure

    New “harvesting heroes” campaign to recognise work of healthcare professionals working in cardiac surgery

    FDA streamlines “compassionate use” application process

    The Medicines Company completes patient enrolment for ORION-1 study of PCSK9si

    Study shows women with migraines to be at higher risk of cardiovascular disease and mortality

    Metallic bioresorbable scaffold “can be considered as an alternative” to polymeric scaffolds

    Philips Minicare I-20 handheld devices receives CE mark

    BioVentrix receives FDA investigative device exemption for ALIVE trial of Revivent

    TAVI with Sapien 3 may be better than surgery for intermediate-risk patients

    European Union agrees new rules for approving medical devices and in vitro diagnostic medical devices

    https://cardiotrial shows orsiro is non inferior to resolute integrity

    Trial shows Orsiro is non-inferior to Resolute Integrity

    Polymer-free coronary stent more effective and safer than bare metal stent in ACS patients

    New procedure uses heart rate to estimate life expectancy of infarct patients

    Medinol announces results for NIREUS trial of BioNIR stent

    ResMed announces primary results for CAT-HF sleep apnoea trial

    HeartFlow haemodynamic data may help predict coronary plaque rupture potential

    Alvimedica TNT session presented at EuroPCR

    St Jude Medical launches new Trifecta GT tissue valve in the USA

    One-year paediatric feasibility study results published for Xeltis bioabsorbable graft

    Corona Regional Medical Center installs Toshiba’s Vantage Titan and Aquilon Prime systems

    iVascular completes recruitment of patients for ANCHOR clinical trial of Angiolite

    Drug-coated balloon is viable alternative to drug-eluting stent

    Edwards’ surgical heart valve innovations demonstrate positive patient benefits

    St Jude Medical launches PressureWire X Guidewire in Europe

    Major new study to investigate abbreviated DAPT in high bleeding risk patients

    Cordis to return to drug-eluting stent market following Biosensors agreement

    Corvia Medical InterAtrial shunt device receives CE mark

    Moderate sedation during TAVI associated with significantly better outcomes

    Young female acute coronary syndrome patients have significantly greater comorbidities than their male counterparts

    Study to directly compare Orsiro with Xience in STEMI patients

    Admedus to attend upcoming US heart conferences

    Medicure files application for new tirofiban hydrochloride product format

    Device reduces volume of radiographic dye in patients at risk of developing acute kidney injury

    No gender-based outcomes variation for two anticoagulants in TAVR patients

    NICE recommends evolocumab for some patients at high risk of cardiovascular events

    Optical coherence tomography helps cardiologist predict significant side branch ostium stenosis

    Robotically-assisted percutaneous coronary intervention feasible in complex cases

    First central Pennsylvania, USA, patients receive new aortic valve reconstruction procedure

    Konica Minolta release updated Sonimage HS1 compact ultrasound

    Patient enrolment completed in REDUCE trial

    Abbott to acquire St Jude Medical

    Enrolment completed in BIOFLOW-V clinical study or Orsiro

    Study finds reasons for hospital-level variations in bleeding post-angioplasty remain unclear

    Scientists report on novel method for extending the life of implantable devices in situ

    Toshiba’s Aquilion Lightning CT with more powerful generator receives FDA clearance

    Admedus expands distribution agreement with Coroneo

    French hospital celebrates 30 years of implanting artificial hearts

    Boston Scientific voluntarily recalls Fetch 2 aspiration catheter

    Impella can now be used in USA for cardiogenic shock after myocardial infarction

    St Jude Medical launches Trifecta surgical valve in Europe

    Deferred stenting in STEMI patients does not improve outcomes

    New sub-analyses show benefit of long-term use of ticagrelor for high-risk myocardial infarction patients

    Early data show good rapid healing for Medtronic’s investigational drug-filled stent

    One-year data for FFRCT support previous findings

    More than 5,000 patients enrolled in iFR outcome trials

    FDA gives Neovasc go-ahead to add 40mm valve size to its TIARA-I clinical trial

    Age is a strong predictor of spontaneous myocardial infarction in medically managed patients

    Toshiba to showcase Aquilion ONE family technology at the 2016 ACC meeting

    Two new publications report on use of PleuraFlow technology

    First patient enrolled in Xenios i-cor cardiac assist system trial

    US FDA grants Humanitarian Use Device status for Xeltis pulmonary valve

    Boston Scientific to present data at American College of Cardiology Scientific Session

    Heart attack patients becoming younger and more obese

    Signs of stress in the brain may signal future heart trouble

    The Medicines Company to present antithrombotic agent data at 2016 ACC meeting

    American College of Physicians recommends prescription drug pricing changes

    Enrolment complete for MiStent optical coherence tomography study

    Stentys Xposition S self-apposing stent receives CE mark for unprotected left main disease

    PCI does not reduce readmission rates for patients with syncope and obstructive coronary artery disease

    OptoWire II FFR guidewire receives FDA 510(k) clearance

    First patient receives CorMatrix’s ECM tricuspid valve

    Adults with congenital heart disease may be at increased risk of post-traumatic stress

    Magnesium Elektron and Biotronik develop bioresorbable magnesium coronary scaffold

    Successful PCI of chronic total occlusions does not improve long-term survival

    SCAI teams up with ASE to raise concerns about new imaging guidance

    Women less likely to receive basic life support for cardiac arrest from public

    Corvia Medical receives FDA investigational device exemption approval for REDUCE LAP-HF study

    Palmaz Scientific seeking prospective buyers following bankruptcy announcement

    Corindus appoints Mark J Toland as president and chief executive officer

    REVA reaches target patient enrolment in FANTOM II trial

    Tirofiban hydrochloride meta-analysis presented at CRT 2016

    ReCor Medical receives IDE approval for RADIANCE-HTN hypertension clinical trial

    Expanded CE mark approval for Z-Medica QuikClot

    TherOx' SSO2

    TherOx adds Keith Grossman to board of directors

    Cardiovascular Systems report 30-day results of COAST trial

    Second USA minimally invasive Trialign procedure performed in Chicago

    First UK Revivent-TC transcatheter ventricular enhancement procedure performed

    First patient enrolled in study of supersaturated oxygen system for acute myocardial infarction

    First two patients treated in study of Peregrine system for renal denervation

    Heart attack patients with cardiogenic shock fair well from 60 days post-discharge

    Makkah’s cardiac hospital describes how it copes with yearly pilgrimage

    Acute vessel wall injury is common after transradial catheterisation but is not linked to radial artery occlusion

    More than 200 patients have been enrolled in Reva Medical’s study of Fantom device

    NeoChord receives German NUB status 1 for DS1000 mitral valve repair system

    European Society of Cardiology announces winners of innovative cardiovascular research grant programme

    CorMatrix Cardiovascular receives 510(k) clearance for the Tyke implantable device for neonate and infant cardiac tissue repair

    FDA Advisory Committee to review AngelMed Guardian system for pre-market approval

    Admedus appoints Wayne Peterson as new chairman of the Board

    First patient enrolled in trial of the COBRA PzF nanocoated coronary stent system

    St Jude Medical launches Optis mobile system in Japan and Europe

    US Medicare to cover Boston Scientific Watchman left atrial appendage closure device

    Corindus appoints Campbell Rogers to its Board of Directors

    Clive Meanwell of The Medicines Company receives innovation and leadership award

    Alexander J Denner appointed to The Medicines Company Board of Directors

    CorMatrix Cardiovascular prosthetic heart valve platform receives 27th patent

    Admedus CardioCel achieves first sales in Middle East and North Africa region

    New sizes of the Medtronic launches new Resolute Onyx drug-eluting stent sizes

    OrbusNeich highlights new generation coronary balloons at AsiaPCR/SingLIVE 2016

    Admedus signs distribution agreement with Coroneo

    Boston Scientific and Accenture develop data-driven digital health platform to improve efficiency and patient outcomes

    New AHA statement says symptoms of myocardial infarction may differ in women

    Roxwood Medical launches Micro14es extra support catheter

    RenalGuard Solutions announces new European clinical trial to evaluate long-term impact of RenalGuard therapy in patients at high risk for CI-AKI

    JenaValve Technology appoints Pieter Van den Steen as chief commercial officer, general manager

    Reva hires Richard Kimes as senior vice president of Operations

    Svelte Medical Systems announces European launch of Slender IDS

    Valentin Fuster awarded Spain’s highest civilian award for services to healthcare

    One-hour diagnosis of heart attack possible with Roche troponin T test

    Conavi Medical receives FDA 510(k) clearance for Foresight intracardiac echocardiography system

    Expert consensus statement for treatment of cardio-oncology patients released by the Society for Cardiovascular Angiography and Interventions

    Japanese Ministry of Health, Labour and Welfare approve Occlutech atrial septal defect closure device

    SurModics acquires NorMedix, a company focused on minimally invasive catheter technologies

    The Medicines Company advances clinical development of investigational PCSK9 synthesis inhibitor for atherosclerotic cardiovascular disease

    HeartWare appoints Stephen Oesterle to board of directors

    Vivasure granted CE mark for world’s first fully bioabsorbable percutaneous closure device for large-bore transcatheter

    Clinical results of Chocolate Heart drug-coated coronary balloon announced by QT Vascular

    New coronary congenital disease classification suggested to aid identification of secondary defects

    Orsiro may provide benefit over Xience for STEMI patients

    Hyperglycaemia could lead to heart attack complications

    Longer treatment times found for heart attack patients with history of bypass graft surgery

    Seeking treatment earlier may improve heart attack outcomes

    Risk of cardiovascular events and death minimised by greater reduction of blood pressure than current guidelines recommended

    MicroPort EP completes first clinical case observation on its cardiovascular catheter sheath

    Coronary heart disease patients with no teeth have nearly double the risk of death

    HeartWare International receives director nominations notice from Engaged Capital

    AdvaMed, MITA & MDMA applaud congress for passage of the medical device tax suspension

    Edward Heart Hospital becomes first in Illinois, USA to use CorPath system for robotic-assisted vascular procedures

    OrbusNeich’s new generation coronary balloons showcased at GulfPCR-GIM 2015

    Radial access used less than femoral approach for emergency angioplasty

    Xeltis extends series B financing to €30 million

    CE mark for Svelte Medical’s sirolimus-eluting coronary stent-on-a-wire integrated delivery system

    Mind the gender gap: Addressing inequalities in interventional cardiology

    Optimism associated with reduced cardiac readmission after acute coronary syndrome

    Roxwood Medical announces full US launch of its MicroCross catheter

    i-cor synchronised cardiac assist preserves left ventricular function compared with continuous-flow ECLS in cardiogenic shock

    New study will evaluate Heart Test Laboratories’ MyoVista heart screening device

    Enrolment completed in randomised trial of MiStent and Xience

    Antonio Colombo joins Scientific Advisory Council of Miracor Medical Systems

    Survey suggests that cardiology is one of the rudest specialties

    Promising results for novel wave membrane blood pump

    BioVentrix Announces first interventional heart failure procedure for left ventricle volume reduction in a pre-clinical model

    Medinol US Commercialises Novel Coronary Stent

    Happiness has no direct effect on mortality

    Arterys partners with GE Healthcare to launch new cardiac imaging platform

    New European code says no to direct sponsorship of physicians to attend congresses but says yes to sponsorship via healthcare organisations

    Heartbeat International foundation and Biotronik open new centre in the Dominican Republic

    Personally tailored diabetes care reduces mortality in women but not men

    Medical titles are “hierarchical” and “hardly appropriate” for person-centred care

    Sedentary patients with heart disease have worse health even if they exercise

    Vascular Solutions’ R350 guidewire receives 510(k) clearance

    i-cor synchronised cardiac assist system recieves CE mark

    FDA issues safety communication on lubricious coating separation from intravascular medical devices

    Occurrence of surgical ‘never events’ unrelated to hospital performance

    Thrombus aspiration does not improve 12-month outcomes according to TATORT-NSTEMI trial

    American Heart Association and Google Life Sciences to collaborate on US$50 million research project

    Moderate coffee consumption may be good for you

    Cardiovascular Systems CEO to take medical leave

    Enrolment begins in the ACIST-FFR multi-centre study

    COURAGE: No long-term benefit with PCI in stable disease

    New risk score could aid decision making about extending dual antiplatelet therapy beyond 12 months

    Fewer “inappropriate” PCI procedures are being performed in the USA

    Study shows extended-release aspirin capsules can deliver sustained antiplatelet effects for 24 hours

    Protein reprogramming method might yield rich source of heart cells for cardiac repair

    WomenHeart appoints three new members to its board of directors

    PEGASUS-TIMI 54 subanalysis provides additional insights into long-term ticagrelor use

    3D system may more accurately identify best donor hearts for a paediatric transplant patients

    Women cardiologists specialise in different areas, and are paid less, than men

    North Carolina scientist awarded American Heart Association Population Research Prize

    New long-term data demonstrates benefit of CardioMEMS HF system over standard therapy

    Group therapy can promote cardiovascular health, according to study

    Wealthiest patients may have edge over sickest in organ transplants

    Xeltis completes second feasibility clinical trial on bioabsorbable cardiovascular technology

    EMA grants CardioCel a broader indication for use in Europe

    World’s largest cardiovascular imaging conference to showcase technological innovations

    TherOx granted FDA IDE Approval to study next-generation supersaturated oxygen therapy for AMI

    Third-generation renal denervation system by ReDy receives CE mark approval

    MC3 Cardiopulmonary acquires surgical cannula product assets from Terumo Cardiovascular Systems

    New data on The Medicines Company’s cardiovascular portfolio to be presented at AHA

    Minimally invasive, leadless endovascular neuromodulation system introduced by Enopace Biomedical

    Custom-designed vascular training model now available at events

    Medeon Biodesign’s XPro large bore vascular closure device achieves successful first-in-man studies

    CardioCel bio-scaffold launched and sold in Malaysia

    American College of Physicians joins brief urging Supreme Court to uphold considerations of race, ethnicity in medical school admissions process

    Tryton Medical files pre-market approval application with US FDA for Tryton Side Branch Stent

    PiCSO highlighted at TCT as novel therapy

    Opsens performs 1,000th procedure with the OptoWire

    Death after heart surgery overwhelmingly determined by patient risk factors

    In-hospital mortality higher for young women after STEMI

    Angioplasty balloon catheter from AV Medical Technologies receives FDA clearance

    Biotronik announces European launch of new generation of Galeo coronary guide wires

    Curbing atherosclerosis and precision medicine should be main strategies to transform the landscape of treatments to prevent heart attacks and strokes

    Edwards Lifesciences appoints Martha Marsh to board of directors

    New guidance issued for multivessel PCI, thrombectomy in heart attack patients

    Spiral Flow PV bypass graft launched by Vascular Flow Technologies

    Antiplatelet therapy with blood thinners reduces mortality for angioplasty patients

    British Heart Foundation announces strategy for over half a billion pounds of research funding

    One-year outcomes from OrbusNeich’s Combo REMEDEE all-comers registry demonstrate clinical effectiveness in target lesion failure

    Neovasc Tiara featured in live case broadcast at TCT 2015 meeting

    Edwards Sapien 3 valve demonstrates high survival and low stroke rate at one year

    SHIELD I trial results confirm consistent cardiac support offered by St. Jude Medical HeartMate PHP cardiac assist device during high-risk PCI procedures

    Lesion preparation with scoring balloon may improve performance of drug-coated balloons in managing in-stent restenosis

    Edwards Sapien XT valve granted FDA approval for aortic valve-in-valve procedures

    Sentinel cerebral protection system provides definite cognitive benefit for TAVI patients

    “Excellent” one-year outcomes for Direct Medical TAVI valve

    Desolve bioresorbable scaffold continues to show low MACE rate at three years

    European DISCHARGE trial will analyse whether CT can replace cardiac catheterisation in patients with suspected coronary disease

    Long-term results of RESPECT indicate that PFO closure may be effective at preventing recurrent stroke

    Medtronic CoreValve System ‘real-world’ US patient experience data replicates clinical outcomes

    Corindus Vascular Robotics and Mayo Clinic Launch Vascular Robotic Program to Research Physician Safety

    Stentys sirolimus-eluting stent confirms best-in-class performance at three years

    Medtronic CoreValve Evolut R System demonstrates strong performance of recapturable and repositionable heart valve yielding low rates of mortality and stroke with excellent hemodynamics

    HeartFlow FFRCT Analysis can lower cost of care by up to 32% and improve quality of life for coronary artery disease

    Medtronic CoreValve System shows low mortality and improved quality of life in new patient populations

    LIVE from TCT: No evidence of scaffold thrombosis with Biotronik’s magnesium scaffold at six months

    LIVE from TCT: Acceptable acute safety profile of Tryton side-branch stent confirmed

    LIVE from TCT: Ranolazine does not reduce adverse events in patients with residual occlusions after PCI

    LIVE from TCT: Promising results for novel drug-filled stent

    Lariat surgical delivery device receives the CE mark

    Gary Lickovitch becomes vice president of sales and service at Corindus Vascular Robotics

    Boston Scientific to present data for wide range of products at TCT

    Elixir will stream its first live case transmission of Desolve at TCT

    Medtronic to unveil new clinical data at TCT

    Cardinal Health completes acquisition of Cordis

    Boston Scientific announces additional investment and right to acquire MValve Technologies

    New test could identify two-thirds of patients at very low risk of heart attack in the emergency department

    Robotic PCI can now be used for radial access procedures in USA

    New randomised trial will compare sutureless valve to standard bioprostheses

    Positive preclinical data for trileaflet repair with CardioCel presented at EACTS

    Medtronic completes acquisition of Twelve

    FDA issues notification about reduced leaflet motion with bioprosthetic aortic valves

    50th patent for HeartFlow secured

    First-in-man implant of MValve Technologies’ transcaheter mitral valve replacement system

    First cohort of patients enrolled in FANTOM II clinical trial

    Post-hoc analysis of Tryton side-branch stent trial published

    Venair collaborates on leading research project with Georgia Institute of Technology

    Biosensors to commercialise BMX-J drug-eluting stent system in Japan

    St Jude Medical collaborates with Mended Little Hearts to produce The Mended Little HeartGuide

    World Heart Day focuses women’s heart health

    Occlutech receives the CE mark for its ventricle septal defect closure device

    Primary endpoint met in HeartMate 3 CE mark trial

    RenalGuard significantly reduces acute kidney injury during TAVI

    CE mark for new TAVI simulation software

    More than 1000 patients have now been treated with Acurate Neo valve

    Medinol completes enrolment of its multicentre trial of eDES

    CeloNova announces FDA approval to start a Cobra PzF coronary stent system randomised trial

    Miracor launches PiCSO impulse system in Asia

    CE mark for 27mm and 29mm of Portico TAVI valves

    First-in-man cases with Mitra-Space presented

    High definition IVUS used for the first time

    Open-label phase 1 study to evaluate off-the-shelf, biomaterial scaffold

    Incoming St Jude Medical president and chief executive officer announces executive leadership team

    First patient enrolled in CeloNova’s e-COBRA clinical registry

    Harpoon Medical enrols ten patients in Early Feasibility Study with 100% procedural success

    Direct transfer of STEMI patients to cath lab reduces mortality

    Sorin and Cyberonics announce appointment of LivaNova’s chief financial officer

    Admedus to present CardioCel data At European cardio-thoracic conference

    Medicure announces filing of sNDA for new Aggrastat indication

    Nipro to acquire Infraredx

    Philips and Catharina Hospital sign technology agreement for largest cardiovascular centre in the Netherlands

    Analysis projects Carillon Mitral Contour System as a cost effective option for functional mitral regurgitation

    Thoratec announces start of SHIELD II US clinical trial

    FDA approves expanded Brilinta indication to include long-term use in patients with a history of heart attack

    Absorb is non-inferior to Xience in ABSORB-Japan

    First patient enrolled in BIOFLOW-VI clinical study in China

    Mitralign given the OK for early feasibility study of its percutaneous tricuspid valve system

    Data show benefits of cangrelor in patients undergoing either radial or femoral approach

    FFRCT significantly reduces the number of invasive tests with no sign of obstructive disease

    HeartWare International to acquire Valtech Cardio

    LIVE from the ESC: Five-year FAME data further confirms benefits of FFR-guided PCI

    LIVE from ESC: No benefit with aldosterone antagonists in acute myocardial infarction

    Philips to showcase integrated cardiology solutions ESC Congress 2015

    Risk of all-cause mortality with post-discharge bleeding after PCI is greater than risk with post-discharge myocardial infarction

    FDA approval for evolocumab

    ESC “very excited” to be in London

    The Medicines Company announces participation at 2015 European Society of Cardiology Congress

    Direct Flow Medical appoints Mary Edwards as vice president of regulatory and clinical affairs

    SentreHEART elects Richard Ferrari to board of directors

    Colibri Heart Valve receives patent for controlled release of percutaneous heart valve device

    Medtronic to buy company that is developing a transcatheter mitral valve implantation device

    2015 TCT late-breaking trials announced

    Clinical trial launched to test if coronary stent patients can avoid taking aspirin

    Cyberonics and Sorin provide merger update

    “We all need the strength” to challenge unacceptable behaviour

    Heart attack patients without obstructive coronary artery disease are at high risk of residual angina

    Corindus Vascular Robotics partners with Unfors RaySafe to help reduce radiation exposure in the cath lab

    Abiomed submits supplements to expand Impella 2.5 FDA pre-market approval

    US Endovascular and BrosMed enter into exclusive agreement to distribute coronary angioplasty catheters

    Interventional cardiology devices market to be worth US$25.16bn by 2020

    Medtronic issues recall for EnVeo R loading system

    Successful testosterone replacement therapy reduces the risk of cardiovascular events and mortality in men

    FDA issues safety warning about left ventricular assist devices

    Tryton Medical completes enrolment in the Extended Access Registry for its Tryton side branch stent

    Nitinol Devices & Components acquires Interface Catheter Solutions to create Confluent Medical Technologies

    Bellerophon Therapeutics announces results from PRESERVATION I clinical trial for Bioabsorbable Cardiac Matrix

    Abbott Vascular expands its structural heart portfolio with new mitral valve technologies

    CorPath system to be featured for the first time in Japan

    First participants enrolled in dabigatran study of AF patients undergoing PCI

    Natec Medical receives FDA approval for Filao NC PTCA balloon catheter

    Survey shows need for greater consistency in “real world” observational research

    New stem cell delivery method shows promise for treating end stage heart failure

    Sunshine Heart provides update on COUNTER HF US study for C-Pulse heart assist system

    Micell Technologies announces first patient enrolled in registration trial of MiStent SES in China

    Hospira announces US launch of generic bivalirudin for injection

    Global bioabsorbable scaffolds market will be worth more than US$2bn by 2021

    EUROMAX substudy suggests transradial approach does not improve clinical outcomes

    Phil Mui joins HeartFlow product and engineering team

    Definitive agreement between St Jude Medical and Thoratec announced

    CE mark and FDA approval for new TAVI guidewire

    Boston Scientific launches bioresorbable scaffold trial

    OrbusNeich announces enrolment of first patient in China Recovery Study

    HeartWare announces first human implants of the MVAD System in CE mark trial

    Vital’s CT myocardial perfusion makes its US debut at SCCT 2015

    US hospital is first hospital in world to use 4D ultrasound software to image heart

    Distal Access sells rights to SPNIR platform to Merit Medical

    Men believe “long working hours” stop women from being interventional cardiologists

    Enrolment in COAST study of orbital atherectomy system completed

    Sorin launch latest generation of its healing and cooling system

    Edwards Lifesciences enters into agreement to buy CardiAQ

    HeartMate PHP now has the CE mark

    FDA approves Promus Element Plus and Promus Premier coronary stent systems

    US generic version of bivalirudin authorised

    FDA strengthen warnings about risk of myocardial infarction with NSAIDS

    Nearly one third of PCI deaths are related to acute kidney injury

    Early discharge after TAVI is feasible in selected patients

    CardioCel shows no evidence of calcification after seven years in long-term follow-up to phase II trial

    Thoratec announces first HeartMate 3 implant in European less invasive surgical trial

    Trend towards better outcomes with sutureless valve for high-risk patients

    Oxford University Press launches European Heart Journal-Quality of Care and Clinical Outcomes

    Bureaucracy leads to delays in patients accessing cardiovascular devices

    Miracor Medical Systems appoints international scientific advisory council

    Cell Therapy reports 100% MACE-free survival after two years in the Heartcel clinical trial

    Cardiac Dimensions announces initial enrolments in REDUCE FMR clinical trial

    FDA approves Medtronic’s CoreValve Evolut R

    Tailored patient education may help to improve adherence to medications

    Admedus granted Cardiocel approval in Singapore

    CardiAQ reports first-in-human percutaneous implantation with its second generation transcatheter bioprosthetic mitral heart valve

    Sapien 3 now approved for use in the USA

    First US patient enrolled in BIOFLOW-V study of Orsiro

    Vascular Solutions introduces two new versions of Turnpike catheters

    CorPath system robotically deploys bioresorbable vascular scaffold during a live PCI broadcast at 2015 C3 Conference

    Randomised controlled trials must be simplified to sustain innovation

    Opsens receives clearance to sell FFR products in the USA

    Philips launches anatomically intelligent quantification tool for cardiac ultrasound imaging

    Visualising calcified coronary arteries may be wake-up call to change lifestyle

    Poor sleep associated with increased risk of heart attack and stroke

    New survey will explore international barriers to adopting TAVI

    Comparable outcomes between PCI and surgery in diabetic patients with acute coronary syndromes and multivessel disease

    Biotectix announces licensing agreement with Acutus Medical for the use of Amplicoat on cardiac catheters

    FDA expands label indication for PleuraFlow to reduce retained blood

    Early healing profile established for BioFreedom

    Article highlights effects of orbital atherectomy and rotational atherectomy in treating heavily calcified coronary lesions

    Isaac George named co-principal investigator of pivotal trial of Direct Flow Medical’s Transcatheter Heart Valve System

    New data add to evidence base for FFR

    Merit Medical Systems launches the Prelude Snap splittable sheath introducer

    Jenavalve appoints Victoria E Carr-Brendel as chief executive officer

    Award for artificial mitral valve pioneer

    Philips launches “first of its kind” on-demand ultrasound service

    Toshiba introduces software upgrades for 3T MRI system

    New 7T MRI research system ready for future clinical use

    New trial does not support earlier findings that complete revascularisation improves outcomes

    Study shows larger capacity intra-aortic balloon pumps to have greater haemodynamic effects

    Thoratec receives conditional FDA approval for the SHILED II US clinical trial for HeartMate PHP

    Abbott announces CE mark for advancement of Absorb stent system for heart disease

    InspireMD CGuard reports positive results at EuroPCR 2015

    REVA releases initial clinical results for Fantom scaffold

    Positive data for Mitralign percutaneous annuloplasty system presented at EuroPCR

    Arterial Remodeling Technologies and Terumo show promising pre-clinical data for drug-eluting bioresorbable scaffold

    EuroPCR 2015 Orsiro hybrid drug-eluting stent data highlights safety and efficacy in high-risk patients

    Elixir Medical announces three-year imaging results for the DESolve scaffold system

    On-X Life to launch Chord-X mitral valve chordal repair system

    Long-term safety and efficacy of BioMatrix drug-eluting stent family confirmed in large international registry

    Biotronik announces successful first implantations of resheathable transcatheter aortic valve

    Data presented at EuroPCR 2015 demonstrate strong performance of Synergy over four years

    Use of CoreValve is as safe and effective as surgery in low risk patients at two years

    Direct Flow Medical reports two-year data for its Transcatheter Aortic Heart Valve System

    Significant differences in achieving risk factor targets between women and men following a heart attack

    OrbusNeich announces initiation of HARMONEE stent study in USA

    Availability of HeartFlow FFRCT Analysis may change the management of patients with coronary artery disease

    Post-market study evaluating the Lotus valve system demonstrates low paravalvular aortic regurgitation rates

    First clinical experience with Stenty’s Xposition shows 100% implantation success

    Post-market study of Direct Flow Medical’s aortic heart valve system demonstrates positive outcomes at 30 days

    Edwards pauses enrolment in early stage mitral programme

    SERVE-HF sleep apnoea trial fails to meet primary endpoint

    Institutional factors play role in cardiac rehab referral rates after angioplasty

    Harpoon Medical enrols patients in study of its repair system for off-pump, minimally invasive treatment of mitral valve regurgitation

    Two-year ORBIT II coronary data and long-term economic data presented at SCAI 2015

    Pie Medical Imaging introduces its newest 3mensio structural heart analysis software

    LRP study enrolls 1,000 patients

    Jean Boulle Group announces first US clinical trial implant of Tendyne transcatheter mitral valve

    ResMed launches AirCurve 10 CS PaceWave for central sleep apnoea

    Medtronic initiates study evaluating potential of combination of pulmonary vein isolation and renal denervation for atrial fibrillation

    STENTYS’ next-generation of self-apposing stent system receives CE mark ahead of plan

    First and only intravenous antiplatelet agent receives the CE mark

    First patient enrolled in Vessix sham-controlled study

    FDA approves feasibility study for CardiAQ Valve Technologies’ transcatheter mitral valve implantation system

    First patient enrolled in Tendyne’s transcatheter mitral valve implantation trial

    Leading cardiovascular societies release new guidance on use of heart pumps

    Publication suggests intraaortic balloon pumps as first line choice for high-risk percutaneous coronary intervention patients

    Direct Flow Medical to broaden SALUS pivotal trial

    FDA grants expanded labelling claim to On-X Life Technologies

    PICSO system has potential to improve myocardial recovery after PCI

    Prognosis is significantly worse with non-access site bleeding

    ORSIF created to advocate for safety in hospital catheterisation labs

    Stem cells may slow the heart’s ageing process

    FDA approves investigational study for new smaller SynCardia Total Artificial Heart

    CardioCel to feature at prominent heart valve conferences

    Biotronik announces European launch of Pantera Pro coronary balloon catheter

    CoreValve is now approved for valve-in-valve procedures in the USA

    Study demonstrates concern for retained blood syndrome after heart surgery

    Toshiba launches single-lane SPDT switches supporting 3rd generation PCI Express

    Sorin Group signs merger agreement with Cyberonics

    First US commercial procedures with the Watchman device

    Surgery is still BEST for multivessel disease in the long run

    CardioKinetix announces results of Chinese trial evaluating Parachute heart failure device

    First patient enrolled in all-comers randomised trial of MiStent compared with Xience

    Abiomed Impella 2.5 receives FDA approval for percutaneous coronary intervention

    HeartIT launches CloudCMR

    TriGuard increases proportion of TAVI patients free from ischaemic brain lesions

    Favourable MitraClip trial data from initial presented at ACC 2015

    Toshiba’s Infinix 4DCT receives FDA clearance with Aquilion PRIME CT configuration

    Boston Scientific receives FDA approval for Watchman left atrial appendage closure device

    CoreValve system sustains superior survival benefit over open heart surgery at two years

    Medtronic to initiate clinical study of Drug-Filled Stent following successful preclinical results

    Study shows Brilinta treatment reduced thrombotic cardiovascular events in patients with a history of heart attack

    CHAMPION data show significant improvement in survival rates for heart failure patients with reduced ejection fraction

    Philips introduces IntelliSpace Cardiovascular at the American College of Cardiology Meeting

    Siemens offers solutions for sustainable cardiovascular care at ACC 2015

    JACC reports on first-in-human transcatheter tricuspid repair

    Ablative Solutions receives innovation award

    Medtronic initiates pivotal studies of Resolute Onyx drug-eluting stent in USA

    Infraredx to launch TVC Imaging System and TVC Muller Extended Bandwidth NIRS-IVUS Catheter at ACC 2015

    CREDIT II stent trial completes enrolment

    Cardiac Dimensions completes US$43m equity financing

    Admedus expands Cardiocel market and anticipates record sales quarter

    Forge Medical reports clinical outcomes of VasoStat haemostasis device at ECR 2015

    Sunshine Heart pauses enrolment in US pivotal study of C-Pulse heart assist system

    Bracco Imaging launches the EmpowerCTA+

    Drug-coated balloons are not inferior to drug-eluting stents for treating stent restenosis

    Peritoneal hypothermia is feasible but does not reduce infarct size in STEMI patients

    OrbusNeich appoints Alain Aimonetti as vice president

    PleuraFlow exhibited at Association of Physician Assistants in Cardiovascular Surgery Meeting

    Alvimedica launches Cre8 46mm

    Aortic regurgitation measurement based on X-ray imaging receives 510(k) clearance

    Cardiovascular Systems releases two-year ORBIT II coronary data

    Worse outcomes after TAVI for patients with moderate-to-severe kidney disease

    Meta-analysis indicates that bivalirudin does increase risk of early stent thrombosis

    Biotronik advances clinical evaluation of latest generation DREAMS scaffold

    CeloNova announces accelerated IDE trial enrolment completion for its Cobra PzF coronary stent

    SynCardia Total Artificial Heart patients experienced acceptable outcomes after one year

    Physician safety and stent savings with robotic-assisted PCI to be presented at CRT 2015

    Medtronic announces CE mark and European launch of the Euphora semicompliant coronary balloon catheter

    Asahi Intecc and Svelte Medical Systems announce manufacturing and co-branding agreements

    Ablative Solutions welcomes hypertension leader to its Scientific Advisory Board

    St Jude Medical launches US study of paediatric mechanical heart valve

    Imaging heart muscle structure could give clues to heart disease

    Stentys announces the publication of new Self-Apposing stent in left main coronary artery study

    LEADERS Free Japan trial completes enrolment

    MicroPort receives CE mark approval for Firehawk

    MiStent now commercially available in Europe

    First-of-their-kind imaging studies presented at TCT

    Biotronik announces completion of patient enrolment for Orsiro BIOFLOW-IV study

    Minimally invasive clip can repair mitral valve regurgitation

    Medtronic expands access to the CoreValve Evolut R System with new valve sizes

    Bellerophon Therapeutics adds to drug and device development capabilities with management additions

    Biosensors enters into distribution agreement with Veryan for BioMimics 3D stent

    Analysis shows first significant advantages for transcatheter aortic valve in patients with prior CABG

    JenaValve appoints Jan Keltjens as interim chief executive

    Sorin announces enrolment completion for the Perceval IDE US study

    NICE issues FAD recommendation of Xarelto to reduce risk of secondary events in acute coronary syndrome

    On-X Life Technologies to launch Chord-X mitral valve chordal repair system

    Abbott’s troponin test may help doctors double the diagnosis of female myocardial infarction

    FEops closes a €1.3m series A financing round to commercialise its TAVIguide service

    Transapical TAVI can be performed with comparable results to transfemoral TAVI in high-volume centres

    Ultrasound has potential for detecting potential heart attacks and stroke before symptoms arise

    Novella Clinical and the Cardiovascular Research Foundation to collaborate on clinical trial expertise

    NuVascular Technologies and Worcester Polytechnic Institute to commercialise stem cell treatment for heart damage

    Transcatheter Technologies to expand portfolio with Tresillo TMVI system

    Micro Interventional Devices completes STASIS clinical trial enrolment

    HeartFlow names new general counsel to executive team

    CytoSorbents submits IDE application for US CytoSorb cardiac surgery trial

    Transcatheter Technologies introduces transfemoral Trinity TAVI system

    Societies publish data standards for cardiovascular endpoints in clinical trials

    First clinical trial implant of the Tendyne transcatheter mitral valve a success

    CHART-1 phase III trial enrols 240th patient

    Sorin announces FDA clearance and first US implant of Memo 3D ReChord annuloplasty ring

    First transcaval valve replacement procedure completed in Europe

    CVRx granted humanitarian device exemption approval for Barostim neo legacy device

    Volcano announces 1,000th system activated with iFR modality worldwide

    HeartFlow appoints William C Weldon to board of directors

    Heart charity offers novel technology grants

    CVRx granted CE mark for the Barostim neo system for conditional MRI compatibility

    Near-infrared spectroscopy may assist in predicting the risk of future cardiovascular events

    Successful first human implants of the Tendyne Transcatheter Mitral Valve Implant

    GulfPCR-GIM 2014

    Too early to say that renal denervation is a failed therapy

    REVA implants first patients with Fantom scaffold

    BIOTRONIK completes enrolment for BIOHELIX-I PRO-Kinetic Energy stent trial

    Neovasc announces treatment of first patient in TIARA-I clinical trial

    Philips launches DoseWise Portal radiation dose management software

    Combined mitral valve repair and CABG do not provide additional benefits

    Baylis Medical expands European reach with new UK office

    FDA allows marketing of non-invasive device to help evaluate heart blood flow

    Investors express confidence in Emblok embolic protection catheter with US$5m financing

    SCAI recommends one year of dual antiplatelet therapy following drug-eluting stent placement in response to DAPT study

    Toshiba Dose Tracking System awarded Novation’s Innovative Technology Designation

    Qvanteq AG enrols first patient in QUEST I clinical study

    BioCardia CardiAMP

    BioCardia CardiAMP phase III clinical trial protocol receives FDA clearance

    New data from EVOLVE clinical programme demonstrate SYNERGY success

    Shockwave Medical announces late breaking results of Lithoplasty study

    Injectable bioresorbable scaffold could revolutionise treatment after STEMI

    Successful use of SynCardia temporary Total Artificial Heart

    UK “lags persistently behind” the rest of Europe in its management of structural heart disease

    Essential Medical receives CE mark approval for X-Seal

    Medtronic launches Resolute Onyx drug-eluting stent following CE mark approval

    STENTYS secures agreement with Micell to distribute its novel drug-eluting stent

    Stentys sirolimus-eluting stent receives CE marking

    Medtronic begins clinical study of investigational pericardial surgical aortic heart valve

    ESC Congress to return to Barcelona and Munich

    CE mark approval and first implant of MEMO 3D ReChord

    NICE issues interim ACD recommending Xarelto (rivaroxaban) 2.5mg as an option for secondary prevention in ACS

    Genetic predisposition to elevated LDL-C associated with narrowing of the aortic valve

    TransMedics Organ Care System heart technology used to perform the world’s first series of adult human heart transplants from donors after circulatory death

    TransMedics Organ Care System used to perform the world’s first series of adult human heart transplants from donors after circulatory death

    Cardio3 Biosciences appoints Warren Sherman as chief medical officer

    HealthTap launches first USA-wide mobile health marketplace

    Restenosis at routine control angiography increases risk of death at four years

    Three studies show benefits of Perceval sutureless valve

    First patient treated with chemical renal denervation in Peregrine Study

    CardioCel to be launched in Canada

    New study will evaluate use of a second-generation stent in under-served populations

    Merit Medical unveils new ThinkRadial website and educational initiative

    Neovasc to initiate TIARA-I Trial after receiving conditional FDA approval

    New ultrasound contrast agent receives FDA approval

    Positive clinical trial results for PleuraFlow for the reduction of hospital complications after heart surgery

    Direct aortic approach with CoreValve is safe and effective

    Interim data from PROACT study confirm patients with On-X Plus 1.5 valve may be safely maintained at anticoagulation levels below current recommended guidelines

    Impact of mental stress on heart varies between men and women

    Ziehm Imaging wins Gold Stevie Winner at the International Business Awards

    Orsiro drug-eluting stent launched in France

    Admedus to showcase Cardiocel at EACTS

    HeartPrint now listed as a Class 1 medical device

    First-in-man percutaneous repair of tricuspid valve performed

    Direct Flow Medical receives CE mark for its enhanced transfemoral delivery system

    Zero-Gravity suspended radiation protection system approved for use in Europe

    AHA/ACC recommends ticagrelor over clopidogrel for NSTE-ACS

    First patient treated in US pivotal trial of cerebral protection device

    Barostim neo system can now be used for heart failure in Europe

    Final NICE guidance recommends high-sensitive troponin tests to help evaluate heart attacks more quickly

    New enhanced contrast-monitoring technology introduced at TCT

    Solo Smart implanted for first time in US

    No severe paravalvular leak with Acurate Neo TF

    The incremental costs of TAVI with CoreValve in high-risk patients are acceptable

    Percutaneous closure of patent foramen ovale reduces migraine with aura days

    First patient enrolled in US trial of Lotus valve system

    Low rate of target vessel revascularisation with Cobra PzF coronary stent

    CE mark for transfemoral Acurate neo

    Sustained safety and performance with Lotus valve at one year

    Carillon mitral contour system is associated with significant and sustained improvements in mitral regurgitation

    Acist launches high-definition IVUS

    Further evidence to support healing benefits of the Combo stent

    Low mortality rate with Self-Apposing stent at two years

    Positive three-year results for the Mistent SES

    All study endpoints met in DIRECT II

    One-year clinical data from European trial shows consistent, compelling positive results for patients treated with minimally invasive device for heart failure

    Significant patient benefits with Sapien valve demonstrated in five-year PARTNER trial data

    ABSORB II study shows Absorb is comparable to Xience drug-eluting stent

    LIVE from TCT2014: Cerebral protection system reduces number of brain lesions after TAVI

    FDA clearance for Medtronic NC Euphora coronary balloon

    First US implants in clinical study of recapturable CoreValve Evolut R

    Micro Interventional Devices initiates “first-in-man” clinical study of Permaseal

    New methods enhance the quality of myocardial perfusion imaging

    CE mark approval for Enabler-C coronary catheter system

    Failure of TRO40303 may question whether reperfusion injury actually occurs in man

    CE mark for recapture CoreValve Evolut system

    Corindus Vascular Robotics to host breakfast symposium at TCT 2014

    Initial patient enrolled in BioFreedom USA

    Heart Hospital of Austin is first in Texas to implant new Portico re-sheathable TAVI device

    Self-Apposing stent has now been implanted more than 10,000 times

    Pre-hospital ticagrelor does not improve coronary reperfusion before PCI in STEMI patients

    FDA 510(k) clearance for TAVI precision treatment planning application

    Claret Medical raises up to US$18 million in Series B financing to advance the field of cerebral protection

    Do not use balloon angioplasty to treat drug-eluting stent restenosis

    Confounders can partly explain obesity paradox in STEMI patients

    CE mark approval for Direct Flow Medical 23mm valve

    Severity of sleep apnoea impacts risk of resistant high blood pressure

    SCAI statement on new report showing heart disease deaths dropped significantly in past decade

    Boston Scientific and ASAHI INTECC announce joint development and manufacturing programmes

    B Wayne Johnson Named OrbusNeich president and chief executive officer

    US Department of Justice closes investigation into PLATO clinical trial for Brilinta

    First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting

    Juventas Therapeutics completes enrolment of phase I/II RETRO-HF trial

    Journal review finds gene therapy for subset of heart disease patients “highly warranted”

    MitraClip system gets US Medicare National Coverage Determination

    JenaValve names Stefan Schreck chief technology officer

    Toshiba Introduces SURESubtraction Coronary at ESC 2014

    Robotic PCI study reveals favourable results

    HeartWare International appoints Katrin Leadley as chief medical officer

    Thoratec announces start of HeartMate PHP CE mark trial

    Study supports a minimalist approach to transfemoral TAVI

    FDA approves SynCardia Total Artificial Heart with SynHall valves

    A simple intervention could prevent acute kidney injury in one in five PCI patients

    Cytori ATHENA trials on clinical hold

    James Thomas joins Northwestern Medicine’s Bluhm Cardiovascular Institute

    ACIST enters co-promotion agreement with Medtronic

    Tryton Medical enrols first patient in the EXTENDED Access registry

    FDA approves Solo Smart aortic pericardial heart valve

    CE mark approval for Crown PRT heart valve

    CE mark approval for Agent drug-coated balloon

    Boston Scientific launches Polaris imaging system

    Results of first-in-human study of Trinity TAVI device reported in EuroIntervention

    Cytori technology selected for NHLBI funded trial in LVAD patients

    NICE extends recommendations for prasugrel

    Miracor Medical begins European launch of next-generation PICSO impulse system

    FDA clearance of CorMatrix ECM for vascular repair

    FDA approves Rebel platinum chromium coronary stent system

    Mitral regurgitation does negatively affect outcomes after TAVI

    Use of delayed consent in HEAT-PPCI was “entirely ethical”

    BIBA MedTech to launch Tavimonitor.org web application service

    InspireMD appoints James Barry as chief operating officer

    CardioVascular institute trial provides treatment for left-sided heart failure

    First patient enrolled in MASCOT registry

    CE mark for new 25mm Lotus valve system

    Paragonix files 510(k) pre-market notification with FDA for Sherpa Perfusion cardiac transport system

    STENTYS expands marketing of the self-apposing stent in South America

    480 Biomedical awarded US$1 million phase II NHLBI contract to advance bioresorbable scaffold

    Clinical hold of REGULATE-PCI following voluntary halt of trial by Regado

    Toshiba launches Infinix Essential, repositions Infinix product line

    First patient enrolled in PROSPECT II study

    JenaValve names David J Drachman chief executive officer

    CardiAQ obtains stay of further proceedings in Neovasc’s pending European patent application covering transcatheter mitral valve replacement

    Thoratec acquires Apica Cardiovascular

    Transradial access predicts survival in NSTEMI patients

    Incidental findings on imaging leads to worse outcomes for prospective TAVI patients

    First European experience with ProTrack at St George’s Hospital London

    CorMatrix completes enrolment of patients in RESTORE

    Spectranetics completes acquisition of AngioScore

    Siemens workshop enhances diagnostic confidence and workflow efficiency within ultrasound

    Philips and Salesforce.com announce a strategic alliance

    Corindus Vascular Robotics receives North American New Product Innovation Award in interventional cardiology

    Fortis Hospitals performs coronary artery bypass surgery through the abdomen

    Simbionix transoesophageal echocardiography training simulator helps learners master clinical skills

    Novel anticoagulation system for PCI patients is effective at supressing ischaemic events without compromising bleeding

    Faster full strut coverage with self-apposing stent

    LEADERS Free Japan trial enrols first patient

    HLT names Kevin Bassett general manager

    Sapien XT launching in USA

    British Cardiovascular Society response to open letter concerning NICE draft guidance on statins

    First patient enrolled in investigator initiated REDUCE study

    CoreValve system receives FDA approval for high-risk patients

    Cardiovascular Systems announces coronary data at late-breaker SCAI 2014

    FDA clears of Chocolate PTCA balloon catheter

    Manual thrombus aspiration associated with a higher rate of direct stenting

    Sapien 3 heart valve could be used in intermediate risk patients

    Stentys to acquire stent delivery technology for its next-generation of self-apposing stents

    New research shows tomato nutrient can help prevent heart disease

    RESPOND post market registry of Lotus valve system initiated

    OrbusNeich releases long-term data for world’s first and only dual therapy stent

    Medtronic announces CE mark approval and launch of NC Euphora coronary balloon

    Enrolment now complete in LEADERS FREE study

    Biosensors announces appointment of new CEO

    EnligHTN III primary results show renal denervation is safe and effective

    Boston Scientific reports strong performance data for Synergy stent system

    Lotus valve system demonstrates strong performance and safety profile at six months

    Small vessel BIOFLOW-II subgroup analyses demonstrate top performance of Orsiro

    SynCardia total artificial heart with SynHall valves receives CE mark approval

    InspireMD to showcase embolic systems with MicroNet Technology and results from MASTER I trial at EuroPCR conference

    Freedom Solo demonstrates low mortality rate at one year

    CE mark approval for DESolve 100 novolimus-eluting coronary scaffold system

    St Jude Medical announces first implants in US study of the Portico transcatheter aortic heart valve system

    IDE approval for BioFreedom US trial

    FDA clears GE’s new Discovery IGS 740 mobile angiography system

    Ablative Solutions strengthens its Scientific Advisory Board

    UK babies set to receive heart test at birth

    Leading cardiac surgeons share their experiences with new technology

    Positive results for iMOS Prime registry for the MGuard Prime embolic protection system

    Fortis launches India’s first comprehensive centre for treatment of end-stage heart failure and transplant

    Eurocor launches Apertus aspiration catheter

    Medtronic reports 3f Enable five-year follow-up data

    Stentys’ self-apposing stent featured in Journal of the American College of Cardiology

    Positive outcomes for CoreValve patients treated via alternative access routes

    Promus Premier everolimus-eluting coronary stent system launches in Japan

    FDA approves Mitroflow aortic heart valve with phospholipid reduction treatment

    CE mark for TIVUS device

    Volcano announces limited market release of SyncVision

    Cardinal Health to acquire AccessClosure

    Ochsner Medical Center buys Toshiba cardiovascular X-ray technology

    Bivalirudin use during percutaneous coronary intervention for non-ST segment-elevation acute coronary syndromes is associated with lower bleeding

    Peri-PCI bleeding in patients with diabetes carries “significant” increased risk of mortality

    Federal Appeals Court agrees to Medtronic request to postpone injunction

    STENTYS appoints medical device executive to its Board of Directors

    Abbott completes enrolment of randomised clinical trials for Absorb

    One-Year clinical data show positive results for patients treated with minimally invasive structural heart device

    Lotus valve system demonstrates strong performance

    JenaValve expands Series C venture financing round

    CE mark approval for Intuity Elite valve system

    CoveValve system demonstrates long-term durability

    ACIST launches RXi rapid exchange fractional flow reserve system

    CE mark for Tryton Medical left main indication

    CE mark approval for Perceval sutureless aortic valve extended age indication

    American College of Cardiology elects Patrick O’Gara president

    Data confirm the Neovasc reducer improves functional capabilities in refractory angina patients

    Boston Scientific platinum chromium coronary stent platform demonstrates low event rates through four years

    Analysis of EUROMAX and HORIZONS-AMI trials of Angiomax (bivalirudin) presented at ACC

    Melody transcatheter pulmonary valve shows positive clinical outcomes in real-world study

    OrbusNeich launches Sapphire II NC coronary dilatation catheter

    AccessClosure launches the next-generation Mynx Ace vascular closure device at ACC

    CoreValve system results superior to open-heart surgery at one year in US pivotal trial

    Medtronic releases results of SYMPLICITY HTN-3

    Enrolment completed in European REMEDEE registry of Combo dual therapy stent

    Takeda to present additional data from EXAMINE trial

    New lifetime risk measure to predict heart disease

    ORBIT II study one-year coronary data to be presented at American College of Cardiology Conference

    Arterial Remodelling signs buyout agreement with Terumo

    Study identifies variables that predict MitraClip procedure failure

    Feminine personality traits are a risk factor for poorer access to care

    Transcatheter Technologies reports six-month follow-up results for pilot study of its Trinity TAVI system

    FDA approves investigative device exemption trial for Cobra PzF

    On-X Life prepares to sell On-X Plus 1.5 aortic heart valve in Europe

    FDA clears Volcano’s iFR Modality

    Neovasc Reducer featured in live case session at Congress of Update in Cardiology and Cardiovascular Surgery

    Morph AccessPro steerable introducer gets CE mark approval

    No extra benefit with dual antiplatelet therapy for aspirin-resistant CABG patients

    New smaller SynCardia Total Artificial Heart will expand therapy

    Neither valve design nor approach affect stroke rate after TAVI

    First human totally endoscopic aortic valve replacements (TEAVR) reported

    New partnership to launch remote robotics programme

    Rebel platinum chromium coronary stent system gets CE mark approval

    Edwards Lifesciences announces first human implants with mitral transcatheter valve system

    Transcatheter Technologies wins ‘Best Business Pitch’ award at “German Venture Day” for its prosthetic aortic heart valve, Trinity

    Medtronic wins European Patent Office ruling

    Head-to-head independent study shows use of GE Healthcare’s Visipaque leads to better image quality

    Long-term safety and efficacy of MiStent SES presented at CRT 2014

    On-X Plus 1.5 aortic heart valve to launch at Society for Cardiothoracic Surgery in Great Britain & Ireland conference

    Philips drives digital imaging innovations at ECR 2014

    Thoratec issues worldwide urgent Medical Device Correction Letter to update its labelling regarding the use of HeartMate II LVAS pocket system controller

    Toshiba partners with Unfors Raysafe for safer X-ray procedures

    Enrolment complete in world’s first study of spontaneous tissue growth technology

    Guidelines provide new disease classification, lower threshold for intervention

    New imaging techniques to detect heart problems

    Fasting may not be necessary for PCI patients

    Baseline activated clotting time values could help to reduce bleeding after TAVI

    HARMONEE study initiated in Japan

    OrbusNeich’s Combo Dual Therapy stent featured at JIM

    First patient’s own stem cells administered in largest-ever trial of stem cell therapy in heart attack patients

    Pioneering heart operation performed for the first time in Leicester

    ORBIT II coronary data to be presented at 2014 Cardiovascular Research Technologies Conference

    New heart disease and stroke risk estimator App now available

    Robotic-assisted coronary angioplasty procedures will be highlighted during CRT 2014

    US trial of Sentinel cerebral protection system approved

    Cardiac Dimensions receives positive reimbursement decision for 120 hospitals across Germany

    Philips reaches enrolment goal in largest ever sleep apnea clinical trial

    Terumo receives CE mark for its new drug-eluting stent, Ultimaster

    Surprising trends in cause of long-term death after percutaneous coronary intervention

    Study finds obesity during pregnancy is independent risk factor for long-term cardiovascular morbidity

    Global Genomics Group completes patient enrolment of discovery cohort in GLOBAL study ahead of schedule

    FDA reviewer says no to cangrelor for PCI

    High sensitivity cardiac troponin T assay may lead to over diagnosis of myocardial infarction

    App for patients with elevated risk of cardiac events launched

    Pattern of higher blood pressure in early adulthood helps predict risk of atherosclerosis in middle-age

    Symptoms of depression causally linked to risk of coronary heart disease in UK Whitehall study

    Claret Medical announces CE mark and European product launch of the Sentinel cerebral protection system

    Admedus CardioCel cleared for sale in the USA

    Sapien XT can now be used for valve-in-valve procedures

    PCI expansion speeds up treatment time

    Neovasc announces first human implant of Tiara transcatheter mitral valve

    Durability testing completed for Transcatheter Technologies’ prosthetic aortic heart valve

    Ultrasound renal denervation system receives CE mark

    Majority of patients believe PCI cures their coronary artery disease

    Recurrent chest discomfort is the most common cause of readmission after PCI

    Edwards Lifesciences launch US trial of Sapien 3 TAVI device in intermediate risk patients

    Royal Philips forms Healthcare Informatics Solutions and Services

    First commercial implant of Elixir Medical’s DESolve takes place in Germany

    On-X Life Technologies receives approval for expanded labelling claim

    Another blow for renal denervation as Covidien ends OneShot renal denervation programme

    CoreValve approved in the USA

    Pacemaker implantation after TAVI does not increase risk of all-cause mortality

    Barostim therapy may be cost-effective for resistant hypertension

    CE mark for catheter that delivers biological therapies to the heart muscles

    First fully repositionable 29mm TAVI device gets CE mark

    Stentys signs first distribution partnership for its stents in Asia

    CE mark clearance for MediValve’s acWire guidewire

    Boston Scientific appoints new chief medical officer for interventional cardiology

    Tryton Medical launches new Bifurcation Institute

    EMA accepts marketing authorisation application for cangrelor

    ACC launches criteria for evaluating stable ischaemic heart disease tests

    CE mark approval expands patient group for Portico TAVI system

    Boston Scientific and The Medicines Company will co-promote Promus Premier in USA

    First mobile CT scanner launched in UK

    Sutureless aortic valve replacement could be first-line therapy for grey-area patients

    Rick Olson named as new vice president of global sales operations at InspireMD

    Global renal denervation market will be worth $171.7m by 2019

    Meta-analysis raises questions about ischaemia-driven revascularisation

    CE mark for new Symplicity system

    HeartWare acquires Circulite

    Siemens launches Artis one angiography system for universal use

    Successful 30-day results for truly repositionable TAVI system

    Esaote showcases its prevention suite at EuroEcho 2013

    New document on transcatheter therapies for mitral regurgitation launched

    FDA approves Boston Scientific’s Promus Premier coronary stent

    CE mark for XL version of Perceval surgical aortic valve

    First implant of new Solo Smart stentless aortic valve

    Alvimedica and CID join forces

    Enrolment completed in DIRECT II study of rapamycin-eluting stents with biodegradable polymer

    Lotus TAVI device implanted for the first time in Europe

    Campless technique may minimise strokes during CABG

    Drug-eluting stents reduce target vessel revascularisation in older patients

    Reclassification with FFR of ambiguous lesions is safe

    Medtronic to resume sales of CoreValve in Germany

    First European implant of Mitroflow Valsalva conduit performed

    Reducer significantly improves functional capabilities in angina patients

    Conservative revascularisation is non-inferior to aggressive revascularisation

    Transradial approach is reasonable in women

    Larger version of Axxess stent now available

    Cardiovascular Research Foundation and Uppsala Clinical Research Center launch joint study to assess intracoronary near infrared spectroscopy

    New device for acute coronary artery perforation

    Self-Apposing stent effective for other indications than acute myocardial infarction

    Oxygen therapy reduces infarct size

    Medtronic to study renal denervation in patients with moderate hypertension

    Resolute Integrity stent outperforms Promus Element stent for longitudinal strength

    Lotus Valve System meets primary performance endpoint in REPRISE II trial

    Positive results for degenerative mitral regurgitation patients with MitraClip

    Drug-eluting balloon revenue to more than double by 2019

    Three-year results from SYMPLICITY HTN-2 shows significant and sustained drops in blood pressure

    Final results of ADVISE II registry demonstrates performance and utility of iFR Modality

    Lower mortality in STEMI patients with MGuard stent

    1000th patient implanted with ACURATE TA

    World’s first study to evaluate live 3D holographic imaging in interventional cardiology completed

    Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure completes enrolment

    Biotronink Japan announces first patients enrolled in BIOFLOW-IV clinical study

    Combo dual therapy stent demonstrates excellent early-healing and durable outcomes at 24 months

    Six-month results confirm no aortic regurgitation with Direct Flow Medical’s TAVI device

    Positive results in Portico Transfemoral CE Trial reported

    EnligHTN I results presented at TCT

    CE mark for Lotus Valve System

    MitraClip approved for use in the USA

    Cardiovascular Systems receives coronary FDA approval

    CoreValve US Pivotal Trial Extreme Risk study to be presented at TCT

    Scoreflex coronary dilatation catheter associated with less in-stent late loss

    Medtronic launches new aspiration catheter for coronary thrombus removal in USA

    Four-month results for self-apposing stent released at TCT

    Jack Lewin is the new president of the Cardiovascular Research Foundation

    Load more

    Most read

    Mayra Guerrero

    Bruno Scheller

    Rafael Sádaba

    Cardiovascular News

    Write to us
    Editorial: Will Date [email protected]
    Advertising: Hannah Shiels [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter Youtube